Researchers from the Brown School at Washington University in St. Louis and the Washington University School of Medicine at have launched a website featuring the Translational Science Benefits Model, a framework for assessing the health and societal benefits of clinical and translational science.
In an increasingly competitive budgetary environment, the framework seeks to help researchers, administrators, and policymakers demonstrate the impact of their work in four distinct domains with many tangible benefits:
The website and video includes explanations of the framework, resources and guidance on how to use the indicators, and case studies that show the path from research to real-world impact. The framework has been used successfully in case studies to prevent human immunodeficiency virus (HIV) and increase access to contraception, treat Wolfram Syndrome, and improve diagnoses of Kidney Cancer and Creutzfeldt–Jakob Disease.
“We hope this model can serve as a bridge between scientists and the community,” said Dr. Douglas Luke, professor at the Brown School. “We want to remind scientists of the societal value of the work they do and encourage community partners to stay engaged with clinical and public health research.”
Washington University is one of more than 50 Clinical and Translational Science Award (CTSA) hubs in the U.S. Members of other CTSA programs working in public health are encouraged to submit case studies, using this submission form. Studies will be posted on the website.Tags: Friday Letter Submission, Publish on May 17